Dose Ranging Study of VX-509, An Oral Selective JAK3 Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis (RA).Roy Fleischmann,George T. Spencer-Green, Frank Fan, Biliana Frankovic,Xia Luo,Thomas Hoock,Nemanja DamjanovARTHRITIS AND RHEUMATISM(2011)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要